Home > Insider Trading > Filing (0000899243-15-003909)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1114220	Keryx Biopharmaceuticals Inc	KERX	Pharmaceutical Preparations (2834)	134087132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1537670	A Scott Holmes	C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-21	5,000	$5.72	54,742	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reporting person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 2,758 shares, with the reporting person's sale of 2,758 shares of common stock at a price of $7.87 per share on July 31, 2015. The reporting person has agreed to pay Keryx $5,935.22, representing the full amount of the profit realized in connection with the short-swing transaction.
The reporting person effected multiple same-way open market purchase transactions on the same day at different prices, ranging from $5.717 to $5.72, through a trade order executed by a broker-dealer. The price reported in Column 4 is a weighted average price. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 45,000 shares of restricted stock.